CLEARVISE AG (ABO.DE) Fundamental Analysis & Valuation

FRA:ABO • DE000A1EWXA4

Current stock price

1.32 EUR
-0.03 (-2.22%)
Last:

This ABO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ABO.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ABO has reported negative net income.
  • In the past year ABO had a positive cash flow from operations.
  • ABO had positive earnings in 4 of the past 5 years.
  • ABO had a positive operating cash flow in each of the past 5 years.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • ABO has a worse Return On Assets (-0.17%) than 66.67% of its industry peers.
  • With a Return On Equity value of -0.44%, ABO is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • The Return On Invested Capital of ABO (0.99%) is worse than 66.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ABO is below the industry average of 5.14%.
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROIC 0.99%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • Looking at the Operating Margin, with a value of 18.24%, ABO is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
  • ABO's Operating Margin has declined in the last couple of years.
  • ABO has a better Gross Margin (96.58%) than 90.48% of its industry peers.
  • In the last couple of years the Gross Margin of ABO has remained more or less at the same level.
Industry RankSector Rank
OM 18.24%
PM (TTM) N/A
GM 96.58%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ABO.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABO is destroying value.
  • ABO has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ABO has been increased compared to 5 years ago.
  • Compared to 1 year ago, ABO has a worse debt to assets ratio.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • ABO has an Altman-Z score of 0.55. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.55, ABO is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of ABO is 21.45, which is on the high side as it means it would take ABO, 21.45 years of fcf income to pay off all of its debts.
  • ABO has a better Debt to FCF ratio (21.45) than 76.19% of its industry peers.
  • ABO has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ABO (1.35) is worse than 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 21.45
Altman-Z 0.55
ROIC/WACC0.28
WACC3.5%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • ABO has a Current Ratio of 1.62. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
  • ABO has a Current ratio of 1.62. This is comparable to the rest of the industry: ABO outperforms 47.62% of its industry peers.
  • A Quick Ratio of 1.62 indicates that ABO should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.62, ABO perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ABO.DE Growth Analysis

3.1 Past

  • ABO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.89%.
  • ABO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.53%.
  • Measured over the past years, ABO shows a small growth in Revenue. The Revenue has been growing by 1.75% on average per year.
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%

3.2 Future

  • ABO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.65% yearly.
  • ABO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.97% yearly.
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

4

4. ABO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Forward Earnings ratio of 18.24, the valuation of ABO can be described as rather expensive.
  • ABO's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, ABO is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 18.24
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • ABO's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, ABO is valued cheaper than 90.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.04
EV/EBITDA 13.7
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • ABO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ABO's earnings are expected to grow with 64.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y115%
EPS Next 3Y64.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ABO.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.44%, ABO is a good candidate for dividend investing.
  • ABO's Dividend Yield is rather good when compared to the industry average which is at 2.32. ABO pays more dividend than 80.95% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ABO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.44%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y115%
EPS Next 3Y64.65%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ABO.DE Fundamentals: All Metrics, Ratios and Statistics

CLEARVISE AG

FRA:ABO (3/27/2026, 7:00:00 PM)

1.32

-0.03 (-2.22%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-14
Earnings (Next)04-15
Inst Owners6.48%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap99.48M
Revenue(TTM)35.41M
Net Income(TTM)-710.00K
Analysts85.71
Price Target2.82 (113.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.44%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-137%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.24
P/S 2.81
P/FCF 9.04
P/OCF 9.04
P/B 0.62
P/tB 0.62
EV/EBITDA 13.7
EPS(TTM)0
EYN/A
EPS(NY)0.07
Fwd EY5.48%
FCF(TTM)0.15
FCFY11.06%
OCF(TTM)0.15
OCFY11.06%
SpS0.47
BVpS2.14
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROCE 1.64%
ROIC 0.99%
ROICexc 1.05%
ROICexgc 1.05%
OM 18.24%
PM (TTM) N/A
GM 96.58%
FCFM 31.06%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ROICexc(3y)3.51%
ROICexc(5y)2.93%
ROICexgc(3y)3.54%
ROICexgc(5y)2.98%
ROCE(3y)4.87%
ROCE(5y)4.15%
ROICexgc growth 3Y9.43%
ROICexgc growth 5Y-12.73%
ROICexc growth 3Y10.43%
ROICexc growth 5Y-12.09%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 21.45
Debt/EBITDA 9.52
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 48.28%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 0.55
F-Score4
WACC3.5%
ROIC/WACC0.28
Cap/Depr(3y)122.48%
Cap/Depr(5y)90.46%
Cap/Sales(3y)45.96%
Cap/Sales(5y)37.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A
EBIT growth 1Y-59.38%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year435.45%
EBIT Next 3Y84.85%
EBIT Next 5YN/A
FCF growth 1Y-69.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.96%
OCF growth 3Y-6.75%
OCF growth 5Y-8.15%

CLEARVISE AG / ABO.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLEARVISE AG?

ChartMill assigns a fundamental rating of 3 / 10 to ABO.DE.


Can you provide the valuation status for CLEARVISE AG?

ChartMill assigns a valuation rating of 4 / 10 to CLEARVISE AG (ABO.DE). This can be considered as Fairly Valued.


What is the profitability of ABO stock?

CLEARVISE AG (ABO.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for ABO stock?

The Earnings per Share (EPS) of CLEARVISE AG (ABO.DE) is expected to grow by 87.82% in the next year.


How sustainable is the dividend of CLEARVISE AG (ABO.DE) stock?

The dividend rating of CLEARVISE AG (ABO.DE) is 6 / 10 and the dividend payout ratio is 0%.